tirzepatide vs semaglutide diabetes Subcutaneously administered for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials - Diabetologia Tirzepatide vs Semaglutide: Which GLP-1

Studies have shown that GLP-1 injections also lead to lower food intake by reducing hunger and cravings

Quick Answer: Tirzepatide does not selectively burn belly fat, but clinical trials show it produces significant overall fat loss, including substantial reductions in visceral abdominal fat through appetite suppression and metabolic regulation

Some women find that one medication causes more fatigue , bloating , or constipation than the other

Losing weight can help improve both insulin resistance and blood sugar levels

2- Improved Mood and Mental Clarity B12 is crucial in producing neurotransmitters like serotonin and dopamine, which boost mood